CLINICAL STUDY: HEART FAILURE
Antecedent hypertension and heart failure after myocardial infarction
A. Mark Richards, MD, PhD ,*,
M. Gary Nicholls, MD, FACC*,
Richard W. Troughton, PhD*,
John G. Lainchbury, MD ,
John Elliott, MB, ChB, PhD ,
Christopher Frampton, PhD*,
Eric A. Espiner, MD*,
Ian G. Crozier, MD*,
Timothy G. Yandle, PhD* and
John Turner, MD
* Christchurch Cardioendocrine Research Group, Christchurch School of Medicine, Christchurch Hospital, Christchurch, New Zealand
Cardiology, Christchurch Hospital, Christchurch, New Zealand
Nuclear Medicine, Christchurch Hospital, Christchurch, New Zealand
Manuscript received June 21, 2001;
revised manuscript received January 3, 2002,
accepted January 11, 2002.
* Reprint requests and correspondence: Dr. A. Mark Richards, Department of Medicine, Christchurch Hospital, Riccarton Avenue, P O Box 4345, Christchurch, New Zealand. barbara.griffin{at}chmeds.ac.nz
OBJECTIVES: We sought to assess the relationship of antecedent hypertension to neurohormones, ventricular remodeling and clinical heart failure (HF) after myocardial infarction (MI).
BACKGROUND: Heart failure is a probable contributor to the increased mortality observed after MI in those with antecedent hypertension. Hence, neurohormonal activation, adverse ventricular remodeling and a higher incidence of clinical HF may be expected in this group. However, no previous report has documented serial postinfarction neurohumoral status, serial left ventricular imaging and clinical outcomes over prolonged follow-up in a broad spectrum of patients with and without antecedent hypertension.
METHODS: Inpatient events were documented in 1,093 consecutive patients (436 hypertensive and 657 normotensive) with acute MI. In 68% (282 hypertensive, 465 normotensive) serial neurohormonal sampling and radionuclide ventriculography were performed one to four days and three to five months after infarction. Clinical outcomes were recorded over a mean follow-up of two years.
RESULTS: Plasma neurohormones were significantly higher in hypertensives than in normotensives one to four days and three to five months after infarction. From similar initial values, left ventricular volumes increased significantly in hypertensives, compared with normotensives. Left ventricular ejection fraction rose significantly in normotensive but not hypertensive patients. Together with higher inpatient (8.1% vs. 4.4%, p < 0.002) and post-discharge mortality (9.5% vs. 5.5%, p = 0.043), hypertensive patients incurred more inpatient HF (33% vs. 24%, p < 0.001) and more late HF requiring readmission to hospital (12.4% vs. 5.5%, p < 0.001). Antecedent hypertension predicted late HF in patients >64 years of age with neurohormonal activation and early left ventricular dilation.
CONCLUSIONS: Antecedent hypertension interacts with age, neurohumoral activation and early ventricular remodeling to confer greater risk of HF after MI.
|
Abbreviations and Acronyms
| | ACE | | angiotensin-converting enzyme | | ADM | | adrenomedullin | | ANP | | atrial natriuretic peptide | | BNP | | brain natriuretic peptide | | cGMP | | cyclic guanosine monophosphate | | CK | | creatine kinase | | ECG | | electrocardiogram | | ET-1 | | endothelin 1 | | HF | | heart failure | | MI | | myocardial infarction | | N-ANP | | aminoterminal atrial natriuretic peptide | | N-BNP | | aminoterminal brain natriuretic peptide |
|
This article has been cited by other articles:

|
 |

|
 |
 
K. A. Britton, J. M. Gaziano, and L. Djousse
Normal systolic blood pressure and risk of heart failure in US male physicians
Eur J Heart Fail,
December 1, 2009;
11(12):
1129 - 1134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Pitt, A. Ahmed, T. E. Love, H. Krum, J. Nicolau, J. S. Cardoso, A. Parkhomenko, M. Aschermann, R. Corbalan, H. Solomon, et al.
History of Hypertension and Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure
Hypertension,
August 1, 2008;
52(2):
271 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kasama, M. Furuya, T. Toyama, S. Ichikawa, and M. Kurabayashi
Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction
Eur. Heart J.,
June 2, 2008;
29(12):
1485 - 1494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Thune, J. Signorovitch, L. Kober, E. J. Velazquez, J. J.V. McMurray, R. M. Califf, A. P. Maggioni, J. L. Rouleau, J. Howlett, S. Zelenkofske, et al.
Effect of Antecedent Hypertension and Follow-Up Blood Pressure on Outcomes After High-Risk Myocardial Infarction
Hypertension,
January 1, 2008;
51(1):
48 - 54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Mollema, S. S. Liem, M. S. Suffoletto, G. B. Bleeker, B. L. van der Hoeven, N. R. van de Veire, E. Boersma, E. R. Holman, E. E. van der Wall, M. J. Schalij, et al.
Left Ventricular Dyssynchrony Acutely After Myocardial Infarction Predicts Left Ventricular Remodeling
J. Am. Coll. Cardiol.,
October 16, 2007;
50(16):
1532 - 1540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Jegger, R. F. da Silva, I. Lartaud, V. Gaillard, X. Jeanrenaud, M. Nasratullah, L. K. von Segesser, J. Atkinson, P. Segers, H. Tevaearai, et al.
Effects of an aging vascular model on healthy and diseased hearts
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1334 - H1343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A Meredith and J. Ostergren
Review: From Hypertension to Heart Failure -- Are There Better Primary Prevention Strategies?
Journal of Renin-Angiotensin-Aldosterone System,
June 1, 2006;
7(2):
64 - 73.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Parodi, N. Carrabba, G. M. Santoro, G. Memisha, R. Valenti, P. Buonamici, E. V. Dovellini, and D. Antoniucci
Heart Failure and Left Ventricular Remodeling After Reperfused Acute Myocardial Infarction in Patients With Hypertension
Hypertension,
April 1, 2006;
47(4):
706 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M C Shibata, J Collinson, A K Taneja, A Bakhai, and M D Flather
Long term prognosis of heart failure after acute coronary syndromes without ST elevation
Postgrad. Med. J.,
January 1, 2006;
82(963):
55 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Magga, M. Puhakka, S. Hietakorpi, K. Punnonen, P. Uusimaa, J. Risteli, O. Vuolteenaho, H. Ruskoaho, and K. Peuhkurinen
Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction
J Appl Physiol,
April 1, 2004;
96(4):
1306 - 1311.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|